Ashley Capoot / CNBC:
Austin-based brain-computer interface company Paradromics raised a $33M Series A and says it achieved an FDA designation that offers an expedited review process — – Paradromics is part of the emerging brain-computer interface, or BCI, industry. — The company has received …
You may also like
Financial Times: Sky Mavis says its crypto-based game Axie Infinity quadrupled DAUs in under 3 months to 2M in October, as some […]
Lauren Feiner / CNBC: Coinbase beats with $2.5B Q4 revenue, $840M net income, and 11.4M monthly transacting users, up from 7.4M in […]
Enlarge / Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, testifies during […]
David McCabe / New York Times: The White House announces plans to combat AI’s risks, including $140M for new research and draft […]